Showing results (201-210 of 389) with videos related to

Sort By:
Pageof 39
The Journal of Clinical Endocrinology and Metabolism|October 13, 2006
Dopamine receptor expression and function in corticotroph ectopic tumorsRosario Pivonello, Diego Ferone, Wouter W de Herder, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 23, 2008
Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotateBart de Keizer, Maarten O van Aken, Richard A Feelders, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 30, 2018
Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumoursW A van der Zwan, T Brabander, B L R Kam, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1997
Renal clearance of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in humansW Klootwijk, E Sleddens-Linkels, R de Boer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
A multicenter phase II randomized controlled trial comparing 177Lu-Dotatate/capecitabine combination treatment with 177Lu-Dotatate monotherapy in patients with neuroendocrine tumorsMorticia N Becx, Johannes Hofland, Eric P Krenning, et al.
Best Practice & Research. Clinical Gastroenterology|April 16, 2013
Peptide receptor radionuclide therapy (PRRT) for GEP-NETsHendrik Bergsma, Esther I van Vliet, Jaap J M Teunissen, et al.
Virchows Archiv : an International Journal of Pathology|July 6, 2000
Adult hyperinsulinemic hypoglycemia not caused by an insulinoma: a report of two casesB C van der Wal, R R de Krijger, W W de Herder, et al.
European Journal of Endocrinology|November 18, 2000
Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenomaF R Nobels, W W de Herder, W M van den Brink, et al.
Pageof 39